Quarterly report pursuant to Section 13 or 15(d)

Stock Warrants

v3.23.1
Stock Warrants
3 Months Ended
Mar. 31, 2023
Text Block [Abstract]  
Stock Warrants
10. Stock Warrants
As of March 31, 2023 and December 31, 2022, the Company had warrants to purchase the underlying common stock outstanding as shown in the table below.
 
    
March 31,
2023
    
December 31,
2022
 
2023 Warrants
     5,000,000        —    
2022 Warrants
     2,034,883        2,034,883  
2020 Warrant
     110,248        110,248  
Pfizer Warrant
     6,320        6,320  
    
 
 
    
 
 
 
Warrants to purchase common stock
     7,151,451        2,151,451  
    
 
 
    
 
 
 
Weighted-average exercise price per share
   $ 10.32      $ 31.00  
    
 
 
    
 
 
 
The following table summarizes information regarding the Company’s warrants outstanding at March 31, 2023:
 
Exercise Prices
  
Shares
Underlying
Outstanding
Warrants
 
  
Expiration Date
 
$ 4.00
     678,294       
August 14, 2023
 
$ 4.00
     1,356,589        February 14, 2028  
$ 4.00
     5,000,000        March 2, 2028  
$392.00
     116,568        May 27, 2023  
    
 
 
          
       7,151,451